Figure 2From: Clinical research of genetically modified dendritic cells in combination with cytokine-induced killer cell treatment in advanced renal cancer Clinical response to gmDCs-CIK treatment patient with renal cancer. CT scans of patient with renal cancer showing lung metastases. (A) arrow, sites are from lung metastases before gmDCs-CIK treatment, (B) arrow, sites are from lung metastases after gmDCs-CIK treatment.Back to article page